Keiichi Akizuki

Years Active: 2020-2022
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Takuro Kameda, Kotaro Shide, Yuki Tahira, Masaaki Sekine, Seiichi Sato, Junzo Ishizaki, Masanori Takeuchi, Keiichi Akizuki, Ayako Kamiunten, Haruko Shimoda, Takanori Toyama, Kouichi Maeda, Kiyoshi Yamashita, Noriaki Kawano, Hiroshi Kawano, Tomonori Hidaka, Hideki Yamaguchi, Yoko Kubuki, Akira Kitanaka, Hitoshi Matsuoka, Kazuya Shimoda
Prognosis of Indolent Adult T-Cell Leukemia/Lymphoma. Viruses 14 (4) (2022)
Naoki Yoshikawa, Hidemi Takeshima, Masaaki Sekine, Keiichi Akizuki, Tomonori Hidaka, Kazuya Shimoda, Ryuji Ikeda
Relationship between CYP3A5 Polymorphism and Tacrolimus Blood Concentration Changes in Allogeneic Hematopoietic Stem Cell Transplant Recipients during Continuous Infusion. Pharmaceuticals (Basel, Switzerland) 14 (4) (2021)
Keiichi Akizuki, Hitoshi Matsuoka, Takanori Toyama, Ayako Kamiunten, Masaaki Sekine, Kotaro Shide, Takuro Kameda, Noriaki Kawano, Kouichi Maeda, Masanori Takeuchi, Hiroshi Kawano, Seiichi Sato, Junzo Ishizaki, Yuki Tahira, Haruko Shimoda, Tomonori Hidaka, Kiyoshi Yamashita, Yoko Kubuki, Kazuya Shimoda
Real-World Data on Clinical Features, Outcomes, and Prognostic Factors in Multiple Myeloma from Miyazaki Prefecture, Japan. Journal of clinical medicine 10 (1) (2020)

Keiichi Akizuki.css-eqlu8i{font-size:small;padding-left:4px;}